UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $73

Benzinga Newsdesk www.benzinga.com Positive 61.8%

Neg 0% Neu 0% Pos 61.8%

UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $67 to $73.